Evidence of a latent precursor (p53 signature) to uterine serous carcinoma

被引：0
|
作者：
Jarboe, E. A.
Pizer, E.
Miron, A.
Crum, C. P.
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Cell Netix Pathol, Seattle, WA USA
[3] Dana Farber Canc Inst, Boston, MA USA
来源：
MODERN PATHOLOGY | 2008年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
950
引用
收藏
页码：208A / 208A
页数：1
相关论文
共 50 条
  • [21] Can immunohistochemical analysis of p53 and WT1 assist in distinguishing uterine serous carcinoma from uterine endometrioid carcinoma
    Egan, JA
    Ionescu, MC
    Eapen, E
    Jones, JG
    Marshall, DS
    LABORATORY INVESTIGATION, 2003, 83 (01) : 188A - 188A
  • [22] P53 mutation analyses support the use of broad histopathologic criteria for the diagnosis of uterine serous carcinoma
    Isacson, C
    Kurman, RJ
    Ellenson, LH
    LABORATORY INVESTIGATION, 1999, 79 (01) : 118A - 118A
  • [23] p53 Signature and Serous Tubal In-situ Carcinoma in Cases of Primary Tubal and Peritoneal Carcinomas and Serous Borderline Tumors of the Ovary
    Leonhardt, Karoline
    Einenkel, Jens
    Sohr, Sindy
    Engeland, Kurt
    Horn, Lars-Christian
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2011, 30 (05) : 417 - 424
  • [24] SEROUS TUBAL INTRAEPITHELIAL CARCINOMA (STIC): P53 SIGNATURE IN WOMEN WITHOUT HIGH RISK OF OVARIAN CANCER
    Barbosa, L.
    Napoleao, B.
    Ribeiro, M.
    Grande, R.
    Ferreira, P.
    Pedro, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A26 - A26
  • [25] High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
    Katharina Bischof
    Stian Knappskog
    Ingunn Stefansson
    Emmet Martin McCormack
    Jone Trovik
    Henrica Maria Johanna Werner
    Kathrine Woie
    Bjorn Tore Gjertsen
    Line Bjorge
    BMC Cancer, 18
  • [26] High expression of the p53 isoform γ is associated with reduced progression-free survival in uterine serous carcinoma
    Bischof, Katharina
    Knappskog, Stian
    Stefansson, Ingunn
    McCormack, Emmet Martin
    Trovik, Jone
    Werner, Henrica Maria Johanna
    Woie, Kathrine
    Gjertsen, Bjorn Tore
    Bjorge, Line
    BMC CANCER, 2018, 18
  • [27] The association between expression of p53 and aggressiveness of serous adenocarcinoma of the uterine cervix
    Lee, Sul
    Lee, Hyun Joo
    Choi, Kyung Un
    Kwon, Byung Su
    Suh, Dong Soo
    Jeong, Dae Hoon
    Kim, Geun Joo
    Lee, Tae Hwa
    Roh, Hyun-Jin
    Kim, Ki Hyung
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2020, 25
  • [28] Granulin-epithelin precursor and p53 in hepatocellular carcinoma
    Cheung, Siu Tim
    Wong, San Yu
    Fan, Sheung Tat
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A82 - A82
  • [29] Distinct subtypes of serous ovarian carcinoma identified by p53 determination
    Lassus, H
    Leminen, A
    Lundin, J
    Lehtovirta, P
    Butzow, R
    GYNECOLOGIC ONCOLOGY, 2003, 91 (03) : 504 - 512
  • [30] Significant Overexpression of HMGAs in Serous Ovarian Carcinoma in Association with p53
    Mahajan, A.
    Gellert, L.
    Yang, X. J.
    Wei, J.
    MODERN PATHOLOGY, 2009, 22 : 226A - 226A
12345